bersacapavir
N/A
Report date: 2026/03/26 20:00:17
NME
Base Information
Drug Namebersacapavir
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[26]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJohnson & Johnson
China Registration ClassN/A
Develop Information
Active CompaniesJanssen Sciences Ireland UcJanssen Research & Development Llc
Inactive CompaniesFisher Biopharma ServicesXian Janssen Pharmaceutical Ltd
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A